Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
120 studies found for:    GLP-1R
Show Display Options
Rank Status Study
1 Unknown  DIabetes REsearCh on Patient sTratification (DIRECT): GLP-1R Agonists
Condition: Diabetes
Intervention: Drug: Exenatide, Liraglutide
2 Completed Effect of GLP-1 Receptor (GLP-1R) Agonists on Cardiac Function and on Epicardial Adipose Tissue (EAT) Volume and on Myocardial TG Content in Obese Diabetics
Conditions: Obesity;   Diabetes
Interventions: Drug: BYETTA treatment;   Drug: Metformine
3 Completed
Has Results
GLP1R Polymorphisms and Response to GLP1
Condition: Diabetes
Intervention: Drug: GLP-1
4 Recruiting The Effect of the GLP-1 Receptor Agonists on Blood Levels of Lipoprotein (a)
Condition: Diabetes Mellitus Type 2
Interventions: Drug: Liraglutide;   Drug: metformin
5 Terminated TANTALUS Therapy in Type 2 Diabetic Patients Intolerant or Inadequately Responsive to GLP-1 Receptor Agonist Therapy
Condition: Diabetes Mellitus, Type 2
Intervention: Device: TANTALUS System
6 Completed PROMASTER - PROspective Cohort MRC ABPI STratification and Extreme Response Mechanism in Diabetes
Condition: Diabetes
Intervention: Drug: second- or third-line glucose-lowering diabetes treatment
7 Recruiting Efficacy and Safety of Toujeo® Versus Tresiba® in Insulin-Naive Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Oral Antihyperglycemic Drug(s) ± GLP-1 Receptor Agonist
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: INSULIN GLARGINE (U300);   Drug: Insulin degludec;   Drug: GLP-1 receptor agonist;   Drug: Glimepiride;   Drug: Metformin
8 Completed Post-Marketing Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Ipragliflozin in Combination With GLP-1 Receptor Agonists in Japanese Patients With Type 2 Diabetes Mellitus (T2DM)
Condition: Type 2 Diabetes Mellitus
Intervention: Drug: Ipragliflozin
9 Completed Glucagon-like Peptide (GLP) Utilization and Safety
Condition: Diabetes Mellitus, Type 2
Interventions: Other: The GLP-1 receptor agonist users;   Other: DPP-4 inhibitor users;   Other: Other ADA users
10 Recruiting Research of Intensive Lifestyle Intervention for PCOS Patients With IGT
Condition: Polycystic Ovary Syndrome
Interventions: Behavioral: intensive lifestyle intervention;   Drug: GLP-1 Receptor Agonists;   Drug: Metformin;   Drug: Acarbose
11 Recruiting Effects of a GLP-1 Receptor Agonist on Functional Activation and Connectivity of the Brain
Condition: Diabetes Mellitus
Interventions: Drug: Lixisenatide;   Other: Placebo
12 Unknown  Effects of GLP-1 Receptor Agonist on Fat Redistribution and Inflammatory Status
Condition: Obesity
Intervention: Drug: Exenatide
13 Recruiting Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination Versus GLP-1 Receptor Agonist in Patients With Type 2 Diabetes
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: insulin glargine/lixisenatide fixed ratio combination;   Drug: liraglutide;   Drug: exenatide;   Drug: exenatide extended-release;   Drug: albiglutide;   Drug: dulaglutide;   Drug: metformin;   Drug: pioglitazone
14 Completed SAFEGUARD: Pleiotropic Effects of Incretin Based Therapies
Condition: Type 2 Diabetes
Interventions: Drug: Liraglutide;   Drug: Sitagliptin;   Drug: Exenatide;   Drug: Liraglutide placebo;   Drug: Sitagliptin placebo;   Drug: Exenatide placebo;   Drug: L-NMMA
15 Recruiting Changes in Bone Turnover With Exposure to a GLP-1 Receptor Agonist
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: exenatide;   Drug: placebo
16 Completed The Effects of Physical Training and GLP-1 Receptor Agonist Liraglutide Treatment in Patients With Type 2 Diabetes
Condition: Type 2 Diabetes
Interventions: Other: Training and liraglutide;   Other: Training and placebo
17 Completed The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and OAD Therapy
Conditions: Diabetes;   Diabetes Mellitus, Type 2
Interventions: Drug: insulin degludec/liraglutide;   Drug: liraglutide;   Drug: exenatide
18 Recruiting The Effect of GLP-1 Receptor Agonist on Cerebral Blood Flow Velocity in Stroke
Condition: Ischemic Stroke
Interventions: Drug: Byetta;   Drug: Normosaline
19 Recruiting The Effect of GLP-1 Receptor Agonist on Cerebral Blood Flow Velocity in Non-stroke Volunteers
Condition: Stroke
Interventions: Drug: Byetta;   Drug: Isotonic saline
20 Recruiting A Comparative Effectiveness Study of Major Glycemia-lowering Medications for Treatment of Type 2 Diabetes
Conditions: Type 2 Diabetes;   Comparative Effectiveness of Glycemia-lowering Medications
Interventions: Drug: Sulfonylurea (glimepiride);   Drug: DPP-4 inhibitor (sitagliptin);   Drug: GLP-1 receptor agonist (liraglutide);   Drug: Insulin (glargine)

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years